Partner News
The section includes updates from partner organizations on related advocacy efforts.
Materials in this section
Global Health Sector Strategy on Viral Hepatitis 2022-2030: Main Aspects
Key strategic and operational shifts required to eliminate chronic viral hepatitis B and C as public health threats by 2030, with priority targets, interventions and innovations. More
HIV Updates From CROI: The Good, the Bad, and the Long-Acting
TAG presented a free webinar unpacking the most significant developments in HIV research presented at CROI 2022, and what they mean for communities affected by HIV. More
President Biden Signals a $6 billion U.S. Pledge for the Seventh Replenishment and Offers to Match $1 for Every $2 Contributed by Other Donors
The Global Fund’s target for the Seventh Replenishment is to raise at least US$18 billion to fund its next three-year (2023-2025) cycle of grants. More
‘Strong Support, Political Will’ Needed to Achieve Global HBV, HCV Elimination Goals
Globally, and at the continent level, viral hepatitis remains a public health threat through 2030, according to research presented at the International Liver Congress 2022. More
Monitoring of Responses to the Hepatitis B and C Epidemics in EU/EEA Countries – 2020 Data
ECDC provides support to EU/EEA countries in monitoring their progress towards the hepatitis elimination targets and published a report based on the second data collection. More
World Hepatitis Summit 2022 Statement
The participants of the third World Hepatitis Summit called on governments, global health agencies and donors to fund comprehensive hepatitis programs. More
New Global Health Sector Strategy on HIV, Hepatitis and STIs 2022-2030 noted at WHA
The Global Health Sector Strategy aims to reignite momentum in the responses to HIV, hepatitis and STIs that had been eroded by disruptions to services during the COVID-19 pandemic. More
Joint Public Health Symposium - Materials Now Available Online
The Joint Public Health Symposium was held on 31 March 2022 as part of the 31st Conference of the Asian Pacific Association for the Study of the Liver (APASL 2022). More
Gilead’s Claim That Generic Purchase of Sofosbuvir Would Lead to Patent Infringement in Brazil Dismissed
Gilead claims there is a patent infringement by two generic producers and directly asked to block any eventual commercialization of sofosbuvir products by these producers in Brazil. More
Fully Fund the Global Fund: Harm Reduction Brief
Joint briefing on harm reduction and the Global Fund replenishment by Harm Reduction International, EHRA, INPUD and the Global Fund Advocates Network. More